---
title: "Exelixis Inc reports results for the quarter ended December 31 - Earnings Summary"
date: "2025-02-12 06:49:45"
summary: "Exelixis Inc reported quarterly adjusted earnings of 48 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of 27 cents. The mean expectation of twenty three analysts for the quarter was for earnings of 43 cents per share...."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

* Exelixis Inc reported quarterly adjusted earnings of 48 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of 27 cents. The mean expectation of twenty three analysts for the quarter was for earnings of 43 cents per share. Wall Street expected results to range from 16 cents to 56 cents per share.
* Revenue rose 18.2% to $566.76 million from a year ago; analysts expected $563.42 million.
* Exelixis Inc's reported EPS for the quarter was 48 cents​.
* The company reported quarterly net income of $139.86 million.
* Exelixis Inc shares had risen by 0.6% this quarter.

FORECAST CHANGES

* The mean earnings estimate of analysts had risen by about 9.5% in the last three months.​
* In the last 30 days, four analysts negatively revised earnings estimates

RECOMMENDATIONS

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy," 9 "hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Exelixis Inc is $37.50

This summary was machine generated from LSEG data February 11 at 10:49 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact [RefinitivNewsSupport@thomsonreuters.com](http://mailto:RefinitivNewsSupport@thomsonreuters.com))

| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| --- | --- | --- | --- |
| Dec. 31 2024 | 0.43 | 0.48 | Beat |
| Sep. 30 2024 | 0.35 | 0.40 | Beat |
| Jun. 30 2024 | 0.30 | 0.77 | Beat |
| Mar. 31 2024 | 0.24 | 0.20 | Missed |

[Reuters](https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3P22VU:0-exelixis-inc-reports-results-for-the-quarter-ended-december-31-earnings-summary/)
